Antiplasmodial activity of pentyloxyamide-based histone deacetylase inhibitors against Plasmodium falciparum parasites. [PDF]
Dawood WA +9 more
europepmc +1 more source
Correction: Histone deacetylase inhibitors inhibit lung adenocarcinoma metastasis via HDAC2/YY1 mediated downregulation of Cdh1. [PDF]
Wang D +8 more
europepmc +1 more source
High-throughput screening identifies the activity of histone deacetylase inhibitors in patient-derived models of soft tissue sarcoma. [PDF]
Danks MR +15 more
europepmc +1 more source
Histone Deacetylase Inhibitors orchestrate epigenetic signalling and alter the nucleoporins and nuclear envelope in cervical cancer. [PDF]
Rani H, Ganai SA, Mahadevan V.
europepmc +1 more source
Histone Deacetylase Inhibitors Promote the Anticancer Activity of Cisplatin: Mechanisms and Potential. [PDF]
Zhou Y +6 more
europepmc +1 more source
Mechanisms of resistance to histone deacetylase inhibitors in acute leukemia. [PDF]
Akbarzadeh MA +2 more
europepmc +1 more source
Synthesis, In Silico, and Biological Evaluation of Non-Hydroxamate Benzoic Acid-Based Derivatives as Potential Histone Deacetylase Inhibitors (HDACi). [PDF]
Al Rahim NAA +8 more
europepmc +1 more source
Characteristic analysis of adverse reactions of histone deacetylase inhibitors based on WHO-VigiAccess. [PDF]
Yin T, Liu Y, Li C, Feng X, Lin Y, Qu Z.
europepmc +1 more source
Histone Deacetylase Inhibitors Target DNA Replication Regulators and Replication Stress in Ewing Sarcoma Cells. [PDF]
Koppenhafer SL +8 more
europepmc +1 more source

